Últimas notícias Gamaleya Institute

Fri, 30/04/2021 - 14:50

Anvisa apresenta dados analisados na avaliação da vacina russa Sputnik v

Health

Anvisa: Adenovirus replication in Sputnik V attested in documents

The request for the import of 66 million doses of the shot was denied on Monday (26). Anvisa listed a number of issues, among which the alleged presence of adenoviruses capable of replicating in the body of patients who receive the jab.

Fri, 05/02/2021 - 09:48

A Força Aérea Brasileira transporta vacinas contra o novo coronavírus até o município de Tabatinga para a vacinação em comunidades indígenas.

Health

Gov’t negotiates purchase of another 30 mi vaccine doses

Talks are being held with the manufacturers of Sputnik V and Covaxin.